A Validation Study of a Multiple Reaction Monitoring-Based Proteomic Assay to Diagnose Breast Cancer.
Yumi KimUn-Beom KangSungsoo KimHan-Byoel LeeHyeong-Gon MoonWonshik HanDong-Young NohPublished in: Journal of breast cancer (2019)
The data demonstrated that an MRM-based proteomic assay that measures plasma levels of three specific peptides can be a useful tool for breast cancer screening and its accuracy is cancer-type specific.